文献速递骨质疏松与代谢性骨病骨肿瘤

不明类型的弥漫性骨折性系统性骨骼组织细胞增生症:一种新型代谢性骨病

Diffuse, fracturing systemic skeletal histiocytosis of unknown type: a novel metabolic bone disease.
PubMed 文献 · Osteoporos Int · 2019-05-30

本文描述一种新型弥漫性骨骼组织细胞增生症,表现为多发性脆性骨折和高破骨细胞活性。通过临床、影像、生化、遗传和病理检查,在排除恶性肿瘤及其他常见代谢性骨病后,开放骨活检显示广泛骨骼组织细胞增生,可能解释弥漫性中轴和附肢溶骨性病变。全外显子测序未发现诊断性结果,高破骨细胞活性标志物在唑来膦酸治疗后正常化。

要点

  • 新型骨骼组织细胞增生症表现为多发性脆性骨折和高破骨细胞活性。
  • 开放骨活检显示广泛骨骼组织细胞增生,可能解释弥漫性溶骨性病变。
  • 高破骨细胞活性标志物在唑来膦酸治疗后正常化。

核心结论

  • 一种新型的伴有高骨转换的骨骼组织细胞增生症,可与其他组织细胞性和溶骨性骨骼疾病相鉴别。

研究设计与样本

  • 对一名表现为髋部骨折和弥漫性骨骼溶骨性病变的亚洲男性进行临床、影像学、生化、遗传和病理组织学检查,以明确诊断。

主要发现

  • 开放骨活检获得多个病理样本,均显示广泛的骨骼组织细胞增生,可能解释弥漫性中轴和附肢溶骨性病变。
  • 通过仔细的病理检查及CD1a和S-100染色阴性,排除了朗格汉斯组织细胞增生症、Erdheim-Chester病和弥漫性囊性骨骼血管瘤病等罕见疾病。
  • 全外显子测序未获得可解释该可能为获得性疾病的诊断性发现。
  • 高破骨细胞活性标志物提示过度的局灶性骨吸收,但在唑来膦酸治疗后正常化。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We describe a novel disease of diffuse skeletal histiocytosis associated with multiple fragility fractures and high osteoclast activity. Clinical, radiographic, biochemical, genetic, and histopathological investigations were performed to characterize the diagnosis of an Asian man who presented with hip fracture and diffuse skeletal lytic lesions. After excluding malignancy and other common metabolic bone diseases, open bone biopsy yielded several pathological samples all showing extensive skeletal histiocytosis likely to explain the diffuse axial and appendicular lytic lesions. Rare disorders such as Langerhans histiocytosis, Erdheim-Chester disease, and diffuse cystic skeletal angiomatosis were excluded through careful pathological examination and lack of CD1a and S-100 staining. Whole exome sequencing did not yield diagnostic findings to explain this likely acquired disease. High markers of osteoclast activity suggested excessive focal bone resorption but normalized after zoledronic acid treatment. A novel disease of skeletal histiocytosis with high bone turnover is differentiated from other histiocytic and lytic skeletal diseases.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Saini R, DiFrancesco LM, Johnston K, et al. Diffuse, fracturing systemic skeletal histiocytosis of unknown type: a novel metabolic bone disease. Osteoporos Int. 2019. PMID: 31147735. doi:10.1007/s00198-019-05021-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。